(Q40498619)

21 September 2017

title

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers (English)

1 reference

21 September 2017

Peter E Vink

13

0 references

James B Dale

James B Dale

14

0 references

Shelly A McNeil

Shelly A McNeil

1

0 references

Joanne M. Langley

Joanne M Langley

3

0 references

Scott A Halperin

2

Scott A Halperin

1 reference

21 September 2017

Bruce Smith

4

1 reference

21 September 2017

Andrew Warren

5

1 reference

21 September 2017

Geoffrey P Sharratt

6

1 reference

21 September 2017

Darlene M Baxendale

7

1 reference

21 September 2017

Mark A Reddish

8

1 reference

21 September 2017

Mary C Hu

9

1 reference

21 September 2017

Steven D Stroop

10

1 reference

21 September 2017

Janine Linden

11

1 reference

21 September 2017

Louis F Fries

12

1 reference

21 September 2017

language of work or name

English

0 references

publication date

12 September 2005

1 reference

Clinical Infectious Diseases

21 September 2017

published in

1 reference

21 September 2017

volume

41

1 reference

21 September 2017

issue

8

1 reference

21 September 2017

page(s)

1114-1122

1 reference

Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group

21 September 2017

cites work

1 reference

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

21 January 2018

1 reference

Resurgence of acute rheumatic fever in the intermountain area of the United States

21 January 2018

1 reference

STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS

21 January 2018

1 reference

THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

21 January 2018

1 reference

Persistence of type-specific antibodies in man following infection with group A streptococci

21 January 2018

1 reference

Epitopes of streptococcal M proteins shared with cardiac myosin

21 January 2018

1 reference

Multiple, heart-cross-reactive epitopes of streptococcal M proteins

21 January 2018

1 reference

Active bacterial core surveillance of the emerging infections program network

21 January 2018

1 reference

Immunogenicity of a 26-valent group A streptococcal vaccine.

21 January 2018

1 reference

New protective antigen of group A streptococci

21 January 2018

1 reference

Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test

21 January 2018

1 reference

M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

21 January 2018

1 reference

Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans

21 January 2018

1 reference

Recall of type specific antibodies in man by injections of streptococcal cell walls

21 January 2018

1 reference

Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart

21 January 2018

1 reference

Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein

21 January 2018

1 reference

Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein

21 January 2018

1 reference

Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes

21 January 2018

1 reference

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

21 January 2018

1 reference

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

21 January 2018

1 reference

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

21 January 2018

1 reference

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/444458

1 reference

21 September 2017

1 reference